Nasamon Wanlapakorn

The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation

Nawarat Posuwan, Nasamon Wanlapakorn, Pattaratida Sa‐nguanmoo et al. · PLoS ONE · 2016 · 100 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong et al. · Vaccines · 2022 · 94 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effects of public health interventions on the epidemiological spread during the first wave of the COVID-19 outbreak in Thailand

Sipat Triukose, Sirin Nitinawarat, Ponlapat Satian et al. · PLoS ONE · 2021 · 77 citations · Full text

Public Affairs, Health Policy, Infectious Diseases +13

Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients

Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan et al. · Scientific Reports · 2021 · 67 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian et al. · Human Vaccines & Immunotherapeutics · 2022 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17